India's plan to bring in marketing rules to curb unethical promotional practices in the country's drug industry faces an indefinite delay after it hit a legal roadblock, marking a setback for public health groups. The country's law ministry has rejected draft marketing rules, which were prepared by the Department of Pharmaceuticals (DoP) after nearly two years of deliberations, saying they cannot be passed under the proposed legal framework, industry sources told Reuters. DoP officials did not respond to requests for comment, and G.N. Raju, secretary at the law ...
Govt's proposed pharma marketing rules hit law ministry roadblock
The law ministry has rejected draft rules prepared by the Department of Pharmaceuticals